Photobiomodulation for the prevention of oral side effects secondary to head and neck cancer therapy: results of a randomised, single-blind clinical trial
PBM showed effectiveness in delaying onset and reducing the severity of oral mucositis and hyposalivation, as well as alleviating pain and dysgeusia at critical moments. However, it had no significant impact on xerostomia, trismus, analgesic use, or oral candidiasis.
Authors
- Mário Pérez‐Sayáns (ORCID: https://orcid.org/0000-0003-2196-9868)
- Pilar Gándara Vila (ORCID: https://orcid.org/0000-0003-2259-7971)
- Andrés Blanco Carrión (ORCID: https://orcid.org/0000-0002-7405-1834)
- Abel Garcı́a Garcı́a (ORCID: https://orcid.org/0000-0002-5911-5537)
- Antonio Gómez‐Caamaño (ORCID: https://orcid.org/0000-0002-9773-4590)
- Gisela Cristina Vianna Camolesi (ORCID: https://orcid.org/0000-0003-0757-638X)
- Irene Beatriz Prado-Pena (ORCID: https://orcid.org/0000-0002-3105-8358)
- Concepción Victoria-Fernández
Institutions
- Universidade de Santiago de Compostela (ES)
- Complejo Hospitalario Universitario de Santiago (ES)
- Instituto de Investigación Sanitaria de Santiago (ES)
Publication Details
- Journal
- Oral Oncology
- Published
- 2025-04-12
- DOI
- https://doi.org/10.1016/j.oraloncology.2025.107266
- Citations
- 5
- Primary Topic
- Oral health in cancer treatment
- Type
- article
- Field-Weighted Citation Impact
- 7.59